# SNDX (Syndax Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Syndax Pharmaceuticals, Inc. reported $289.7M in revenue and a net loss of $209.5M for the trailing twelve months ended September 30, 2026 (up 81.6% year over year), with a -61.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/SNDX
- Markdown: https://convexityos.com/fundamentals/SNDX.md
- SEC CIK: 0001395937
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:31 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001395937&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $289.7M | +81.6% YoY |
| Operating Income | TTM | -$178.6M | -61.7% margin |
| Net Income | TTM | -$209.5M | -72.3% net margin |
| Diluted EPS | TTM | -$2.33 | Split-adjusted |
| Free Cash Flow | TTM | -$323.2M | -111.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $427.1M | Total debt: $344.6M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $172.4M | $23.68M | $0 | $0 | $139.7M | $1.52M | $1.52M | $1.52M | $2.11M | $1.22M |
| Research & Development | $258.8M | $241.6M | $163.0M | $118.5M | $88.25M | $50.44M | $42.99M | $60.11M | $48.20M | $31.66M |
| Selling, General & Admin | $179.7M | $120.9M | $66.92M | $33.26M | $25.24M | -- | -- | -- | -- | -- |
| Total Operating Expenses | $445.4M | $363.4M | $230.0M | $151.8M | $113.5M | $72.94M | $59.06M | $77.39M | $64.06M | $44.99M |
| **Operating Income** | -$273.1M | -$339.7M | -$230.0M | -$151.8M | $26.22M | -$71.42M | -$57.54M | -$75.88M | -$61.95M | -$43.77M |
| **EBITDA** | -$267.1M | -$331.7M | -$218.0M | -$118.8M | $69.22M | -$71.33M | -$57.45M | -$75.80M | -$61.88M | -$43.68M |
| Interest Income | $22.73M | $26.09M | $21.16M | $5.87M | $403K | $841K | $1.57M | $1.94M | -- | -- |
| Interest Expense | $6.0K | -$1.0K | $208K | $3.14M | $1.90M | $2.36M | -- | -- | -- | -- |
| Income Tax Expense | $433K | -- | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$285.4M | -$318.8M | -$209.4M | -$149.3M | $24.93M | -$73.16M | -$56.05M | -$73.96M | -$60.80M | -$44.47M |
| Basic EPS | -$3.29 | -$3.72 | -$2.98 | -$2.46 | $0.48 | -$1.87 | -$1.84 | -$2.92 | -$2.90 | -$3.22 |
| **Diluted EPS** | -$3.29 | -$3.72 | -$2.98 | -$2.46 | $0.46 | -$1.87 | -$1.84 | -$2.92 | -$2.90 | -$3.22 |
| Basic Shares Outstanding | 86.6M | 85.6M | 70.4M | 60.8M | 52.1M | 41.3M | 30.5M | 25.4M | 21.0M | 14.6M |
| Diluted Shares Outstanding | 86.6M | 85.6M | 70.4M | 60.8M | 53.6M | 41.3M | 30.5M | 25.4M | 21.0M | 14.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $83.30M | $72.79M | $64.86M | $68.73M | $45.87M | $37.96M | $20.04M | $7.68M |
| Research & Development | $67.48M | $68.04M | $58.84M | $78.64M | $56.28M | $62.23M | $61.64M | $65.53M |
| Total Operating Expenses | $125.2M | $112.8M | $99.07M | $131.3M | $103.3M | $107.3M | $103.8M | $104.0M |
| **Operating Income** | -$41.90M | -$39.99M | -$34.20M | -$62.55M | -$57.43M | -$69.35M | -$83.76M | -$96.36M |
| **EBITDA** | -$35.90M | -$34.99M | -$30.20M | -$59.55M | -$54.43M | -$69.35M | -$83.76M | -- |
| Interest Income | $5.59M | $3.75M | $3.56M | $4.33M | $5.27M | $5.95M | $7.18M | $7.11M |
| Interest Expense | $2.0K | $2.0K | $0 | $0 | $0 | $4.0K | $2.0K | -$124K |
| Income Tax Expense | $0 | $0 | $0 | $433K | $0 | $0 | $0 | -- |
| **Net Income** | -$49.43M | -$49.36M | -$42.67M | -$68.01M | -$60.72M | -$71.85M | -$84.85M | -$94.17M |
| Basic EPS | -$0.55 | -$0.55 | -$0.48 | -- | -$0.70 | -$0.83 | -$0.98 | -- |
| **Diluted EPS** | -$0.55 | -$0.55 | -$0.48 | -- | -$0.70 | -$0.83 | -$0.98 | -- |
| Basic Shares Outstanding | 89.8M | 89.0M | 88.3M | -- | 86.6M | 86.3M | 86.2M | -- |
| Diluted Shares Outstanding | 89.8M | 89.0M | 88.3M | -- | 86.6M | 86.3M | 86.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $134.9M | $154.1M | $295.4M | $74.36M | $222.0M | $115.2M | $24.61M | $33.77M | $35.17M | $23.84M |
| Short-Term Investments | $259.1M | $418.8M | $275.3M | $401.4M | $218.0M | $177.8M | $35.17M | $47.14M | $94.81M | $81.49M |
| **Cash & Short-Term Investments** | $394.1M | $572.9M | $570.7M | $475.8M | $439.9M | $293.1M | $59.77M | $80.91M | $130.0M | $105.3M |
| Accounts Receivable, Net | $38.00M | $7.60M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $32.75M | $366K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $528.1M | $603.1M | $580.9M | $489.8M | $448.4M | $298.9M | $62.33M | $83.35M | $133.4M | $108.5M |
| Property, Plant & Equipment, Net | $181K | $0 | $8.0K | $20K | $278K | $192K | $281K | $373K | $267K | $260K |
| Long-Term Investments | $0 | $119.5M | $29.83M | $5.47M | $0 | -- | -- | -- | $3.25M | -- |
| Other Non-Current Assets | -- | $0 | $463K | $807K | $0 | $1.27M | $197K | $219K | $231K | $243K |
| **Total Non-Current Assets** | $1.62M | $121.8M | $32.00M | $7.45M | $1.26M | $1.75M | $1.19M | $592K | $3.74M | $503K |
| **Total Assets** | $529.7M | $724.8M | $612.9M | $497.2M | $449.7M | $300.6M | $63.52M | $83.94M | $137.2M | $109.0M |
| Accounts Payable | $16.58M | $11.63M | $9.96M | $4.35M | $5.67M | $3.51M | $6.18M | $1.44M | $2.23M | $2.38M |
| Short-Term Debt | $343.9M | $343.7M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $1.52M | $1.52M | $1.52M | $1.57M | $1.22M |
| **Total Current Liabilities** | $120.1M | $103.5M | $58.10M | $29.07M | $20.68M | $18.87M | $18.37M | $16.11M | $15.80M | $10.37M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $11.62M | $13.13M | $14.65M | $16.76M | $14.22M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $1.0K | $5.0K | $136K | $310K | $288K |
| **Total Non-Current Liabilities** | $345.0M | $333.1M | $588K | $722K | $20.61M | $29.55M | $13.56M | $14.79M | $17.07M | $14.51M |
| **Total Liabilities** | $465.1M | $436.7M | $58.68M | $29.79M | $41.29M | $48.42M | $31.93M | $30.89M | $32.87M | $24.87M |
| **Total Debt (incl. Leases)** | $345.4M | $345.7M | $1.61M | $1.14M | $1.07M | $417K | $897K | -- | -- | -- |
| Common Stock | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $3.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$1.51B | -$1.22B | -$902.4M | -$693.0M | -$543.7M | -$568.6M | -$495.5M | -$439.4M | -$366.1M | -$305.3M |
| **Total Stockholders' Equity** | $64.63M | $288.1M | $554.2M | $467.4M | $408.4M | $252.2M | $31.60M | $53.05M | $104.3M | $84.14M |
| Total Equity | $64.63M | $288.1M | $554.2M | $467.4M | $408.4M | $252.2M | $31.60M | $53.05M | $104.3M | $84.14M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $135.9M | $336.5M | $130.9M | $134.9M | $116.8M | $108.6M | $154.0M | $154.1M |
| Short-Term Investments | $291.2M | $211.4M | $221.2M | $259.1M | $319.2M | $346.6M | $358.2M | $418.8M |
| **Cash & Short-Term Investments** | $427.1M | $547.9M | $352.1M | $394.1M | $436.0M | $455.2M | $512.2M | $572.9M |
| Accounts Receivable, Net | -- | -- | -- | $38.00M | -- | -- | -- | $7.60M |
| Inventory | $39.38M | $33.16M | $34.95M | $32.75M | $25.00M | $17.70M | $4.66M | $366K |
| **Total Current Assets** | $567.4M | $675.0M | $471.2M | $528.1M | $529.8M | $531.7M | $548.8M | $603.1M |
| Property, Plant & Equipment, Net | $206K | $212K | $177K | $181K | $128K | $0 | $0 | $0 |
| Long-Term Investments | $124.0M | $27.22M | -- | $0 | $20.15M | $62.63M | $89.94M | $119.5M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $125.2M | $28.61M | $1.49M | $1.62M | $21.96M | $64.47M | $91.96M | $121.8M |
| **Total Assets** | $692.7M | $703.7M | $472.7M | $529.7M | $551.8M | $596.1M | $640.7M | $724.8M |
| Accounts Payable | $3.57M | $4.87M | $10.84M | $16.58M | $13.83M | $17.35M | $10.05M | $11.63M |
| Short-Term Debt | $344.1M | $344.0M | $344.0M | $343.9M | $343.9M | $343.8M | $343.8M | $343.7M |
| **Total Current Liabilities** | $121.0M | $99.68M | $86.17M | $120.1M | $114.2M | $113.0M | $94.55M | $103.5M |
| **Total Non-Current Liabilities** | $588.9M | $588.9M | $344.9M | $345.0M | $322.2M | $325.7M | $331.1M | $333.1M |
| **Total Liabilities** | $709.9M | $688.6M | $431.0M | $465.1M | $436.4M | $438.7M | $425.6M | $436.7M |
| **Total Debt (incl. Leases)** | $344.6M | $344.5M | $344.5M | $345.4M | $344.2M | $344.2M | $344.2M | $345.7M |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K |
| Retained Earnings | -$1.65B | -$1.60B | -$1.55B | -$1.51B | -$1.44B | -$1.38B | -$1.31B | -$1.22B |
| **Total Stockholders' Equity** | -$17.18M | $15.10M | $41.62M | $64.63M | $115.4M | $157.4M | $215.1M | $288.1M |
| Total Equity | -$17.18M | $15.10M | $41.62M | $64.63M | $115.4M | $157.4M | $215.1M | $288.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$285.4M | -$318.8M | -$209.4M | -$149.3M | $24.93M | -$73.16M | -$56.05M | -$73.96M | -$60.80M | -$44.47M |
| Depreciation & Amortization | $6.00M | $8.00M | $12.00M | $33.00M | $43.00M | $90K | $92K | $78K | $76K | $89K |
| Stock-Based Compensation | $47.50M | $43.03M | $30.95M | $16.02M | $13.32M | $9.06M | $6.00M | $6.20M | $5.45M | $4.71M |
| Change in Receivables | -$30.39M | -$7.60M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$32.09M | -$366K | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Change in Payables | $4.95M | $1.67M | $5.61M | -$1.32M | $2.16M | -$2.67M | $4.74M | -$792K | -$194K | $923K |
| **Operating Cash Flow** | -$323.0M | -$274.9M | -$160.6M | -$133.7M | $29.13M | -$71.26M | -$50.61M | -$68.53M | -$47.37M | -$35.16M |
| Capital Expenditure | -$187K | $0 | $0 | $0 | -$129K | $0 | -- | -$187K | -$84K | -$261K |
| **Free Cash Flow** | -$323.2M | -$274.9M | -$160.6M | -$133.7M | $29.00M | -$71.26M | -- | -$68.72M | -$47.45M | -$35.42M |
| **Investing Cash Flow** | $290.0M | -$219.8M | $117.6M | -$186.2M | -$40.87M | -$142.5M | $12.78M | $51.40M | -$17.07M | -$18.28M |
| **Financing Cash Flow** | $13.68M | $353.4M | $264.1M | $172.3M | $118.5M | $304.4M | $28.57M | $15.73M | $75.72M | $54.20M |
| **Net Change in Cash** | -$19.27M | -$141.3M | $221.1M | -$147.6M | $106.7M | $90.63M | -$9.26M | -$1.40M | $11.28M | $762K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$49.43M | -$49.36M | -$42.67M | -$68.01M | -$60.72M | -$71.85M | -$84.85M | -$94.17M |
| Depreciation & Amortization | $6.00M | $5.00M | $4.00M | $3.00M | $3.00M | $0 | $0 | -- |
| Stock-Based Compensation | $15.29M | $14.01M | $12.05M | $11.25M | $12.08M | $13.79M | $10.38M | $12.30M |
| Change in Receivables | -$1.80M | -$7.19M | $120K | -$12.59M | -$5.95M | -$3.73M | -$8.12M | -$7.60M |
| Change in Inventory | -$6.02M | $1.84M | -$2.06M | -$7.80M | -$7.18M | -$12.92M | -$4.19M | -$366K |
| Change in Payables | -$1.30M | -$5.97M | -$5.74M | $2.75M | -$3.53M | $7.31M | -$1.58M | $6.73M |
| **Operating Cash Flow** | -$27.25M | -$30.27M | -$50.34M | -$69.49M | -$70.53M | -$87.80M | -$95.16M | -$57.39M |
| **Investing Cash Flow** | -$176.5M | -$16.91M | $38.39M | $81.58M | $72.43M | $41.89M | $94.14M | -$269.0M |
| **Financing Cash Flow** | $3.19M | $252.8M | $7.92M | $5.92M | $6.28M | $551K | $930K | $347.4M |
| **Net Change in Cash** | -$200.5M | $205.6M | -$4.04M | $18.01M | $8.17M | -$45.36M | -$90K | $21.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -158.4% | -1434.4% | -- | -- | 18.8% | -4708.2% | -3792.9% | -5001.7% | -2939.0% | -3587.4% |
| **Net Profit Margin** | -165.6% | -1346.1% | -- | -- | 17.8% | -4822.5% | -3694.6% | -4875.5% | -2884.3% | -3645.2% |
| Return on Equity (ROE) | -441.6% | -110.6% | -37.8% | -31.9% | 6.1% | -29.0% | -177.4% | -139.4% | -58.3% | -52.9% |
| Return on Assets (ROA) | -53.9% | -44.0% | -34.2% | -30.0% | 5.5% | -24.3% | -88.2% | -88.1% | -44.3% | -40.8% |
| Current Ratio | 4.40x | 5.82x | 10.00x | 16.85x | 21.68x | 15.84x | 3.39x | 5.18x | 8.45x | 10.47x |
| Quick Ratio | 4.12x | 5.82x | 10.00x | 16.37x | 21.27x | 15.53x | 3.25x | 5.02x | 8.23x | 10.16x |
| Debt to Equity | 5.34x | 1.20x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x | -- | -- | -- |
| **Revenue Growth (YoY)** | +627.8% | -- | -- | -100.0% | +9109.6% | 0.0% | 0.0% | -28.0% | +72.8% | +94.6% |
| Operating Income Growth (YoY) | -- | -- | -- | -678.8% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -699.1% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -612.5% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -558.9% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -560.9% | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +5317.8% | +455.9% | -100.0% | -100.0% | +3115.6% | -99.6% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -78.3% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -61.7% | -77.0% | -102.8% | -158.2% | -275.1% | -433.7% | -786.6% | -1434.4% |
| **Net Profit Margin** | -72.3% | -87.5% | -111.9% | -165.4% | -279.3% | -428.5% | -757.5% | -1346.1% |
| Return on Equity (ROE) | -- | -1462.1% | -584.4% | -441.6% | -269.9% | -212.8% | -154.0% | -110.6% |
| Return on Assets (ROA) | -30.2% | -31.4% | -51.5% | -53.9% | -56.5% | -56.2% | -51.7% | -44.0% |
| Current Ratio | 4.69x | 6.77x | 5.47x | 4.40x | 4.64x | 4.71x | 5.80x | 5.82x |
| Quick Ratio | 4.37x | 6.44x | 5.06x | 4.12x | 4.42x | 4.55x | 5.75x | 5.82x |
| Debt to Equity | -- | 22.82x | 8.28x | 5.34x | 2.98x | 2.19x | 1.60x | 1.20x |
| **Revenue Growth (YoY)** | +81.6% | +91.8% | +223.6% | +794.9% | +267.0% | +984.5% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
